Moderate

Atopic dermatitis / eczema flare (atopic eczema)

Eczema flare · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Chronic, pruritic, inflammatory skin-barrier disease; the ED sees acute flares and superinfection. Treatment is step-care: skin hydration/emollients + topical anti-inflammatories, with systemic therapy reserved for severe disease. DRAFT for clinician review.

Red flags

  • Punched-out, monomorphic vesicles/erosions = eczema herpeticum (needs oral/IV aciclovir — see separate entry)
  • Rapidly spreading honey-coloured crusting with systemic features
  • Erythroderma (>90% BSA) with temperature/fluid dysregulation
  • Eyelid/periorbital involvement with eye pain or visual change (consider AKC or ocular HSV)
  • Failure to respond to appropriate topical therapy (reconsider ACD, scabies, CTCL)

Assessment

Differential diagnosis

  • Allergic contact dermatitis
  • Irritant contact dermatitis
  • Psoriasis
  • Seborrheic dermatitis
  • Scabies
  • Dermatophyte (tinea) infection
  • Eczema herpeticum (if punched-out monomorphic erosions)
  • Cutaneous T-cell lymphoma (adults with refractory 'eczema')

Investigations

  • Clinical diagnosis; grade severity (e.g. POEM)
  • No routine bloods
  • Bacterial skin swab NOT routine (universal S. aureus colonization) — only if treatment-resistant/recurrent or unusual organism suspected
  • Viral swab / HSV PCR if eczema herpeticum suspected

Management

  • Assess severity and body-surface extent
  • Identify and remove triggers (irritants, allergens, heat/sweat, stress, infection)
  • Maximise emollient use + bathing practices
  • Apply topical corticosteroid by potency ladder to involved skin
  • Use topical calcineurin inhibitor for face/folds or steroid-sparing
  • Recognise and treat bacterial/viral superinfection
  • Wet wraps for severe flares
  • Short systemic steroid only as a bridge in adults/adolescents
  • Refer/admit for eczema herpeticum, erythroderma, severe infection or systemic compromise

Drugs & doses

Emollient (thick fragrance-free cream or ointment) — apply liberally at least twice daily, more often during flares, immediately after bathing. 30 g covers an adult once; prescribe adequate quantity.
Diluted bleach bath 0.005% — 0.5 cup (~120 mL) of 6% household bleach in a full 150 L / 40-gallon tub (or 1 scant tsp per gallon / ~4 L); soak 5–10 min, 2–3×/week (daily if severe/recurrent crusting). For moderate–severe AD.
Low-potency topical corticosteroid (groups 5–6), e.g. hydrocortisone 2.5% ointment or desonide 0.05% ointment — once–twice daily for 2–4 weeks. Mild disease and special sites (face, folds, genitals); first-line for babies/young children.
Medium-to-high-potency topical corticosteroid (groups 2–4), e.g. triamcinolone 0.1%, mometasone furoate 0.1%, fluocinolone 0.025% — once–twice daily for 2–4 weeks for moderate–severe disease. Limit high-potency (groups 2–3) to 2 weeks twice daily / 4 weeks once daily on the body, and 3–4 days on face/neck/folds.
Topical calcineurin inhibitor — tacrolimus 0.03%/0.1% ointment or pimecrolimus 1% cream, twice daily. Steroid-sparing for face/eyelids/folds or persistent disease; not on actively infected skin.
Oral antibiotic for extensive honey-coloured crusting/weeping (bacterial superinfection): a cephalosporin, typically cephalexin orally 2–3×/day, OR a penicillinase-resistant penicillin, for 5–7 days. [Source gives agent class, frequency and duration; exact mg dose not specified — dose per local impetigo protocol.] (See existing 'Infected eczema flare' entry.)
Short-course systemic glucocorticoid — ADULTS/ADOLESCENTS ONLY for acute severe flare needing rapid relief: prednisone 40–60 mg/day × 3–4 days, then 20–30 mg/day × 3–4 days, then 10 mg/day × 4 days. Maximum 3–4 weeks total; continue topical therapy while tapering to prevent rebound. Virtually never in children (bridging only).
Sedating first-generation antihistamine (diphenhydramine, hydroxyzine or cyproheptadine) at night — ONLY for sleep disturbance from itch; optimal dose not established. Oral antihistamines are NOT recommended for the itch itself (no efficacy).

Disposition

Most discharged with a written step-care plan and dermatology/GP follow-up. Admit or arrange urgent specialist review for eczema herpeticum, erythroderma, severe/systemic superinfection, or failure of outpatient therapy.

Complications & pitfalls

  • Bacterial superinfection (S. aureus impetiginization)
  • Eczema herpeticum
  • Eczema coxsackium
  • Erythroderma
  • Sleep disturbance / impaired quality of life
  • Steroid atrophy, striae, telangiectasia with overuse
  • Ocular effects (glaucoma/cataract) from eyelid steroid

Exam pearls

  • Emollients are the backbone — undertreatment ('steroid phobia') and inadequate quantities are top causes of failure
  • Bleach baths work via an anti-inflammatory, not antimicrobial, effect
  • Once-daily topical steroid is about as effective as twice daily
  • Avoid systemic steroids when possible (rebound on withdrawal)
  • Food-elimination diets do not help unselected AD

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.